Background illustration for clinical trials search

Paid Clinical Trials Louisiana

Discover 785 paid clinical trials in Louisiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa
Location: Johnston RI, Quebec, Miramar FL, Miami FL, Toronto,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07170917

Phase2, Recruiting

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

for
Immune Thrombocytopenia
Location: Danvers MA, Boston MA, The Bronx NY, Albany NY,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07007962

Phase3, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Flushing NY, East Orange NJ, Philadelphia PA,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190209

Phase3, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: New Bedford MA, Quebec, Victoriaville, Trois-Rivieres,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190222

Phase3, Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Maspeth NY, New York NY, Philadelphia PA,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184944

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Providence RI, Worcester MA, New Haven CT, Maspeth NY,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184996

Phase3, Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Maspeth NY, New York NY, Fayetteville NC, Miami FL,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07185009

Phase3, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Providence RI, Worcester MA, Maspeth NY, Freehold NJ,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184931

Phase3, Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

for
Moderate-to-Severe Atopic Dermatitis
Location: The Bronx NY, Robbinsville NJ, Tamarac FL, Savannah GA,
Sponsor: Nektar Therapeutics

Sex: All

Age: 12+

Code: NCT07711418

Phase3, Recruiting

A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism

for
Hypoparathyroidism
Location: Albany NY, Homestead FL, Summerville SC, Greenville NC,
Sponsor: MBX Biosciences

Sex: All

Age: 18+

Code: NCT07699471

Phase3, Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

for
Moderate-to-Severe Atopic Dermatitis
Location: New York NY, Clifton NJ, Wilmington NC, Boca Raton FL,
Sponsor: Nektar Therapeutics

Sex: All

Age: 12+

Code: NCT07690371

Phase3, Recruiting

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg Ulcers

for
Venous Leg Ulcer
Location: Slidell LA
Sponsor: NuScience Medical Biologics, LLC

Sex: All

Age: 18+

Code: NCT07061613

Recruiting

ELEVATE-HFpEF Clinical Study

for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Location: Boston MA, Hartford CT, Burlington VT, Wynnewood PA,
Sponsor: Medtronic Cardiac Rhythm and Heart Failure

Sex: All

Age: 40+

Code: NCT06678841

Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne

for
Acne
Location: Jacksonville FL, Brandon FL, New Orleans LA, Encino CA
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT07013747

Phase1, Phase2, Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

for
Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis,
Location: Boston MA, Providence RI, New York NY, Glen Burnie MD,
Sponsor: Spyre Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07012395

Phase2, Recruiting

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

for
Platinum-resistant Ovarian Cancer,
Location: Montreal, Toronto, Pittsburgh PA, Grand Rapids MI,
Sponsor: MacroGenics

Sex: Female

Age: 18+

Code: NCT06730347

Phase2, Recruiting

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs

for
Degenerative Disc Disease (DDD)
Location: Richmond VA, West Palm Beach FL, Port Charlotte FL,
Sponsor: ReGelTec, Inc.

Sex: All

Age: 22 - 70+

Code: NCT06011551

Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: Boston MA, Providence RI, Stony Brook NY, Sherbrooke,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase3, Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

for
Acne
Location: Brighton MA, Marlborough MA, Quebec, Sherbrooke,
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT06316297

Phase1, Phase2, Recruiting

A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

for
Plasma Cell Myeloma Refractory
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT06356571

Phase2, Recruiting

Popular cities in Louisiana

Baton RougeNew OrleansShreveport